Avita Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $213k | 20k | 10.76 |
| 2024-06-30 | $159k | 20k | 7.93 |
| 2024-03-31 | $232k | 15k | 16.05 |
| 2023-12-31 | $184k | 13k | 13.79 |
| 2023-09-30 | $193k | 13k | 14.69 |
| 2023-06-30 | $240k | 14k | 17.02 |
| 2023-03-31 | $149k | 11k | 14.06 |
| 2022-12-31 | $100k | 15k | 6.62 |
| 2022-03-31 | $96k | 11k | 8.50 |